IP Library › Assignment 060592/0646
Patent Assignment
Reel/Frame 060592/0646

Assignment of Assignor's Interest

Recorded: 2022-07-06 Pages: 19
Assignor
ORPHAZYME A/S
Executed: 2022-06-09
Assignee
KEMPHARM, INC.
1180 CELEBRATION BLVD., SUITE 103, CELEBRATION, FLORIDA, 34747
Covered Properties (36)
Use of HSP70 as a Regulator of Enzymatic Activity
Application: 14/330,235 →
Publication: US 2015/0004151
Use of HSP70 as a Regulator of Enzymatic Activity
Application: 17/688,189 →
Publication: US 2022/0362234
Methods for Increasing Intracellular Activity of HSP70
Application: 16/698,473 →
Publication: US 2020/0188492
Use of a Hydroximic Acid Halide Derivative in the Treatment of Neurodegenerative Diseases
Application: 14/594,817 →
Publication: US 2015/0126551
Heat Shock Protein Inducers and Frontotemporal Disorders
Application: 16/615,893 →
Publication: US 2020/0085812
Arimoclomol for Treating Glucocerebrosidase Associated Disorders
Application: 16/092,070 →
Publication: US 2019/0111041
Arimoclomol for Treating Glucocerebrosidase Associated Disorders
Application: 17/574,239 →
Publication: US 2022/0133707
Heat Shock Proteins and Cholesterol Homeostasis
Application: 17/106,825 →
Publication: US 2021/0186949
HSP70 Protein Levels in Pbmc Samples as Biomarker for Disease
Application: 17/059,516 →
Publication: US 2021/0164997
Processes for Preparing Arimoclomol Citrate and Intermediates Thereof
Application: 17/691,989 →
Publication: US 2022/0273639
Use of Arimoclomol in the Treatment of Niemann Pick Disease
Application: 63/130,438 →
Use of Arimoclomol in the Treatment of Niemann Pick Disease
Application: 63/185,111 →
Use of Arimoclomol in the Treatment of Niemann Pick Disease
Application: 17/560,549 →
Publication: US 2022/0211687
Use of HSP70 as a Regulator of Enzymatic Activity
Patent: 8,540,985 →
Application: 13/001,316 →
Publication: US 2011/0286993
Use of HSP70 as a Regulator of Enzymatic Activity
Patent: 9,289,472 →
Application: 13/969,944 →
Publication: US 2014/0050714
Use of HSP70 as a Regulator of Enzymatic Activity
Patent: 9,884,058 →
Application: 15/048,483 →
Publication: US 2016/0263096
Use of HSP70 as a Regulator of Enzymatic Activity
Application: 15/854,352 →
Publication: US 2018/0185349
Use of HSP70 as a Regulator of Enzymatic Activity
Application: 16/698,277 →
Publication: US 2020/0113888
Use of HSP70 as a Regulator of Enzymatic Activity
Application: 16/698,092 →
Publication: US 2020/0121668
Methods for Increasing Intracellular Activity of HSP70
Patent: 9,662,375 →
Application: 13/885,553 →
Publication: US 2013/0230506
Methods for Increasing Intracellular Activity of HSP70
Application: 15/600,407 →
Publication: US 2017/0266263
Hydroxylamine Derivatives Useful for Enhancing the Molecular Chaperon Production and the Preparation Thereof
Patent: 6,653,326 →
Application: 08/860,582 →
Method of Enhancing Cellular Production of Molecular Chaperon, Hydroxylamine Derivatives Useful for Enhancing the Chaperon Production and the Preparation Thereof
Patent: 7,148,239 →
Application: 10/618,157 →
Publication: US 2004/0019103
Method of Enhancing Cellular Production of Molecular Chaperone, Hydroxylamine Derivatives Useful for Enhancing the Chaperone Production and the Preparation Thereof
Patent: 7,745,465 →
Application: 10/618,162 →
Publication: US 2004/0067940
N-[2-Hydroxy-3-(1-Piperidinyl)Propoxy}Pyridine-1-Oxide-3-Carboximidoyl Chlorine and Its Use in the Treatment of Unsulin Resistance
Patent: 6,649,628 →
Application: 09/913,263 →
Pyridine-1-Oxide Derivative, and Process for Its Transformation into Pharmaceutically Effective Compounds
Patent: 7,126,002 →
Application: 10/257,755 →
Publication: US 2004/0006232
Use of a Hydroximic Acid Halide Derivative in the Treatment of Neurodegenerative Diseases
Patent: 8,962,604 →
Application: 13/229,862 →
Publication: US 2012/0115908
Optically Active Pyridyl-4H-1,2,4-Oxadiazine Derivative and Its Use in the Treatment of Vascular Diseases
Patent: 6,384,029 →
Application: 09/762,949 →
Carboxamidine Derivatives and Their Use in the Treatment of Vascular Diseases
Patent: 7,384,936 →
Application: 10/501,029 →
Publication: US 2006/0058294
Pharmaceutically Effective Compounds
Patent: 7,361,655 →
Application: 10/889,966 →
Publication: US 2005/0043295
Carboxamidine Derivatives and Their Use in the Treatment of Vascular Diseases
Patent: 7,691,849 →
Application: 11/981,376 →
Publication: US 2009/0075993
Pharmaceutically Effective Compounds
Patent: 7,550,457 →
Application: 11/981,422 →
Publication: US 2008/0058323
Arimoclomol Formulation
Application: 15/511,094 →
Publication: US 2017/0239232
Arimoclomol Formulation
Application: 16/826,733 →
Publication: US 2020/0261437
Arimoclomol for Treating Glucocerebrosidase Associated Disorders
Application: 16/879,198 →
Publication: US 2020/0289497
Heat Shock Proteins and Cholesterol Homeostasis
Application: 16/093,283 →
Publication: US 2019/0201389
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 14, 2011
From: JENSEN, THOMAS K.; JAATTELA, MARJA H.
To: ORPHAZYME APS C/O COBIS A/S
Reel/Frame 025803/0876 →
Corrective Assignment to Correct the Name of Assignee Previously Recorded on Reel 025803 Frame 0876. Assignor(S) Hereby Confirms the Assignment. Mar 28, 2011
From: JENSEN, THOMAS K.; JAATTELA, MARJA H.
To: ORPHAZYME APS
Reel/Frame 026034/0761 →
Assignment of Assignor's Interest May 16, 2013
From: JENSEN, THOMAS KIRKEGAARD; HINSBY, ANDERS MORKEBERG
To: ORPHAZYME APS
Reel/Frame 030425/0450 →
Change of Name Apr 11, 2018
From: ORPHAZYME APS
To: ORPHAZYME A/S
Reel/Frame 045911/0992 →
Assignment of Assignor's Interest Oct 10, 2018
From: HINSBY, ANDERS MØRKEBERG; JENSEN, THOMAS KIRKEGAARD; FOG-TONNESEN, CATHERINE KOLSTER; TORP PETERSEN, NIKOLAJ HAVNSØE
To: ORPHAZYME A/S
Reel/Frame 047116/0650 →
Assignment of Assignor's Interest Feb 15, 2019
From: JENSEN, THOMAS KIRKEGAARD; MØRKEBERG, ANDERS
To: ORPHAZYME A/S
Reel/Frame 048341/0663 →
Security Interest Sep 6, 2019
From: ORPHAZYME A/S; ORPHAZYME US, INC.
To: KREOS CAPITAL VI (UK) LIMITED
Reel/Frame 050294/0026 →
Assignment of Assignor's Interest Sep 19, 2019
From: JENSEN, THOMAS KIRKEGAARD; JAATTELA, MARJA H.
To: ORPHAZYME A/S
Reel/Frame 050435/0727 →
Assignment of Assignor's Interest Dec 16, 2019
From: JENSEN, THOMAS KIRKEGAARD
To: ORPHAZYME A/S
Reel/Frame 051294/0344 →
Assignment of Assignor's Interest Dec 16, 2019
From: GREENSMITH, LINDA
To: UCL BUSINESS PLC
Reel/Frame 051294/0472 →
Assignment of Assignor's Interest May 6, 2020
From: JENSEN, THOMAS KIRKEGAARD; JAATTELA, MARJA H.
To: ORPHAZYME A/S
Reel/Frame 052593/0815 →
Assignment of Assignor's Interest May 6, 2020
From: JENSEN, THOMAS KIRKEGAARD; MØRKEBERG, ANDERS
To: ORPHAZYME APS
Reel/Frame 052593/0848 →
Change of Name Jul 16, 2020
From: ORPHAZYME APS
To: ORPHAZYME A/S
Reel/Frame 053223/0579 →
Assignment of Assignor's Interest Jul 17, 2020
From: BIOREX KUTATO ES FEJLESZTO RT (VA); BRX RESEARCH AND DEVELOPMENT COMPANY LTD.
To: CYTRX CORPORATION
Reel/Frame 053241/0975 →
Assignment of Assignor's Interest Jul 17, 2020
From: URBANICS, RUDOLF
To: CYTRX CORPORATION
Reel/Frame 053242/0011 →
Change of Name Jul 17, 2020
From: ORPHAZYME APS
To: ORPHAZYME A/S
Reel/Frame 053242/0608 →
Assignment of Assignor's Interest Jul 17, 2020
From: GREENSMITH, LINDA; BURNSTOCK, GEOFFREY
To: BIOREX RESEARCH AND DEVELOPMENT COMPANY RT (VA)
Reel/Frame 053237/0314 →
Assignment of Assignor's Interest Jul 17, 2020
From: CYTRX CORPORATION
To: ORPHAZYME APS
Reel/Frame 053237/0259 →
Change of Name Aug 5, 2020
From: UCL BUSINESS PLC
To: UCL BUSINESS LTD
Reel/Frame 053403/0053 →
Assignment of Assignor's Interest Aug 13, 2020
From: JENSEN, THOMAS K.; JAATTELA, MARJA H.
To: ORPHAZYME APS
Reel/Frame 053485/0472 →
Assignment of Assignor's Interest Aug 13, 2020
From: JENSEN, THOMAS K.; JAATTELA, MARJA H.
To: ORPHAZYME APS
Reel/Frame 053485/0468 →
Assignment of Assignor's Interest Dec 3, 2020
From: INGEMANN, LINDA; JENSEN, THOMAS KIRKEGAARD
To: ORPHAZYME A/S
Reel/Frame 054532/0922 →
Assignment of Assignor's Interest Mar 11, 2021
From: JENSEN, THOMAS KIRKEGAARD; DALI, CHRISTINE Í; PETERSEN, NIKOLAJ HAVNSØE TORP; BLAETTLER, THOMAS
To: ORPHAZYME A/S
Reel/Frame 055558/0839 →
Assignment of Assignor's Interest Jun 1, 2021
From: JENSEN, THOMAS KIRKEGAARD; DALI, CHRISTINE Í.; PETERSEN, NIKOLAJ HAVNSØE TORP; BLAETTLER, THOMAS
To: ORPHAZYME A/S
Reel/Frame 056398/0195 →
Assignment of Assignor's Interest Jul 30, 2021
From: JENSEN, THOMAS KIRKEGAARD; IKONEN, ELINA; GUNGOR, BURCIN
To: ORPHAZYME A/S
Reel/Frame 057028/0960 →